Genmab A/S S/Adr

(GMXAY)

By |

Profile

Genmab A/S is an antibody company focused on cancer. Its first marketed product is Arzerra (ofatumumab); development pipeline incl. daratumumab and two proprietary technology platforms; DuoBody (bispecifics) & HexaBody (effector function enhancement).

Contact Information

Website: www.genmab.com
Main Phone: +45 70202728
Address: Bredgade 34E
City / Town: Copenhagen K
Country: DNK
Postal Code: 1260

Issuer Information

Exchange: OTO
Employees: 189
$ 103.42 $ 4.18 (4.21%)
Last Price 103.42 Change $ 4.18 Change % 4.21 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 101.08 High 103.75 Low 100.75 Prev Close 99.24
Last Trade Volume 184,195 52 Wk Hi 117.75 52 Wk Low 81.05
Market Cap 12.6 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 122,171,348.00 EPS (TTM) 1.33 PE Ratio 77.80 Exchange OTCPK